https://idataresearch.com/wp-content/themes/lambda-child-theme/images/footer-logo.png
https://idataresearch.com/wp-content/themes/lambda-child-theme/images/idata-white-logo.png

Asia-Pacific

Showing 17–32 of 34 results

Patient Monitoring Market Analysis, Size, Trends | Asia-Pacific | 2014-2022 | MedSuite

The market for patient monitoring includes multi-parameter vital sign monitors, wireless ambulatory telemetry monitors, electromyogram (EMG) devices and consumables, electroencephalogram (EEG) monitors, fetal and neonatal monitors and pulse oximetry monitors and sensors.

more...

Female and Neonatal Diagnostic Devices Market Analysis, Size, Trends | Global | 2016-2022 | MedSuite

Industry Trends The majority of these U.S. female and neonatal diagnostic devices market segments will see stable growth throughout the forecast period of this report. The largest segment of this market was represented by breast imaging. This is primarily due to the large number of screening procedures performed with these devices, which add to the

more...

Vascular Access Devices Market Analysis, Size, Trends | Asia-Pacific | 2015-2021 | MedSuite

The vascular access devices market in the Asia-Pacific region encompass implantable ports, port needles, central venous catheters, dialysis catheters, peripherally inserted central catheters and peripheral intravenous catheters. The Asia-Pacific vascular access devices market report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our “ground up” approach, which includes primary and secondary research methods.

The report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our “ground up” approach, which includes primary and secondary research methods.

more...

Infusion Therapy Market Analysis, Size, Trends | Asia-Pacific | 2014-2020 | MedSuite

Infusion therapy devices are used for administering fluids or medication directly into a vein. Some disease states are too severe to be treated with oral medications, and must be treated intravenously. This is generally facilitated with an intravenous (IV) bag that is connected to a catheter inserted into a vein using plastic IV tubing. Infusion can be achieved simply through gravity drip, which uses gravity to introduce fluids into a patient’s vasculature or through the use of an electronic pump. Initially, connecting tubing to the catheter inserted into the patient was done by spiking a needle into a connector on the catheter. However, due to concerns over needlestick injuries and the increased incidence of infection when infusing with non-closed systems, some markets have shifted towards the use of needle-free connectors. Physicians now have the option of connecting the tubing to the inserted catheter using male luer connections and other connectors that accept blunt cannulas.
In 2013, the Asia-Pacific market for infusion therapy devices included volumetric infusion pumps, syringe infusion pumps, disposable infusion pumps, IV tubing sets, needleless connectors and stopcocks. These categories are segmented based on the type of displacement used, the type of infusion being performed and the type of medication and fluid infused. There are several other accessories commonly used during infusion therapy, such as disinfecting caps and three-way stopcocks; however, these aren’t included in the total market value for this report.
Additionally, needleless connectors are not included in the overall market value in this chapter, as they are present only in Australia and Japan, but not in South Korea. The information for each needleless connector market can be found in each country’s respective chapter.

more...

Spinal Implants and VCF Market Report Suite | Asia-Pacific | 2014-2020 | MedSuite

The Asia-Pacific markets for spinal implants are a major component of the global spinal implant market. This report covers the major spinal implant markets (excluding MIS) within the Asia-Pacific region, and includes Australia, Japan and South Korea. All major market segments are detailed, including spinal fusion implants, non-fusion implants and vertebral compression fracture (VCF) treatments.
Major changes and developments are expected to occur within this industry over the forecast period, particularly in the field of non-fusion implants. Across the Asia-Pacific region, the VCF and non-fusion segments will experience high growth compared to the slower growing, but larger and more established fusion market.
The spinal implant market is considered by many to be the most exciting and controversial segment of the orthopedics market. Though the spinal implant market has traditionally been viewed as a segment within the orthopedics market, many manufacturers view spine as a key business division separate from traditional orthopedics.
For the purposes of this report, the Asia-Pacific spinal fusion market is segmented into cervical fixation, thoracolumbar fixation and interbody devices.
In addition to the spinal fusion market, this report includes dynamic stabilization, artificial discs and VCF, as segments of the total spinal implant market. The most major change in this market is expected to be the emergence and increasing prevalence of motion preservation technology.

more...

Spinal Implants and VCF Market Report Suite | Asia-Pacific (China, Taiwan) | 2014-2020 | MedSuite

Despite the geographical proximity of China and Taiwan, the spinal implant markets (excluding MIS) in these two countries differ substantially. The Taiwanese spinal implant market is mature and stable. As a result, the majority of growth in Taiwan is due to the proliferation of newer technologies, including artificial discs and percutaneous vertebral augmentation (PVA). Conversely, in China, increasing access to healthcare in rural areas, more healthcare investment and a growing number of trained orthopedic surgeons have led to rapid growth in nearly every spinal implant market segment.
The spinal implant market is considered by many to be the most exciting and controversial segment of the orthopedics market. Although the spinal implant market has traditionally been viewed as a segment within the orthopedics market, many manufacturers view spine as a key business division separate from traditional orthopedics.
For the purpose of this report, the Chinese and Taiwanese spinal fusion market (excluding MIS) is separated into cervical fixation, thoracolumbar fixation and interbody device segments. In addition to the spinal fusion market, this report includes dynamic stabilization, artificial discs and vertebral compression fractures (VCF) as segments of the total spinal implant market.
Major changes and developments are expected to take place in this market over the forecast period, with the most notable change being the emergence and increasing prevalence of motion preservation technology.

more...

Minimally Invasive Spinal Devices Market Report Suite | Australia, Japan, South Korea | 2014-2020 | MedSuite

The spinal implant market is considered by many to be the most exciting and controversial segment of the orthopedics industry. This market has traditionally been a segment of the orthopedics market, but due to rapid growth and a large market size, many manufacturers view spine as a key business division separate from traditional orthopedics. Historically, the majority of spinal implants were implanted in open surgical procedures through large incisions. However, open surgery can cause considerable tissue damage and lead to a large number of complications. Minimally invasive techniques, which require only small puncture wounds, have been developed for the implantation of a number of spinal implant types. Minimally invasive surgery (MIS) methods are frequently used for implanting traditional spinal implant devices, such as interbody devices and pedicle screws.
Rapid growth is expected in all segments of the Asia-Pacific minimally invasive spinal implant market as a result of the physiological and surgical advantages of MIS procedures over open procedures. MIS spine procedures are expected to maintain double-digit growth rates through the forecast period, while the MIS spine market value will grow at a slower rate due to declining prices.

more...

Minimally Invasive Spinal Devices Market Report Suite | Asia-Pacific (China, Taiwan) | 2014-2020 | MedSuite

The Chinese market for minimally invasive surgery (MIS) spinal devices is the least mature and fastest growing market in the Asia-Pacific region due to the high number of untreated potential patients. Similar to the other BRIC (Brazil, Russia, India, China) countries, access to healthcare in rural areas of China is extremely limited. As a result of economic growth and an initiative by the Chinese government to vastly improve healthcare, a large number of previously untreated spine patients in China’s rural population are now undergoing minimally invasive spine surgery due to increased access.
However, the Chinese government still faces significant challenges in providing medical services adequate to meet the basic needs of an immense number of potential patients spread over a wide geographic region. Although China’s per capita income has grown at a rapid pace since the 1980s, a significant number of Chinese people live at socioeconomic levels far below the national average. The Chinese spinal implant market is experiencing strong growth in all segments. Even traditional spinal fusion, which grows slowly in most countries as a result of market saturation, was increasing rapidly in China in 2013. The MIS segment is the fastest growing industry in the Chinese spinal implant market because it is at its infancy in this country and facing an explosive demand.
China’s market characteristics are vastly different than those of neighboring Taiwan. The Taiwanese spinal implant market is a mature market for fusion products; the majority of growth is a result of newer technologies, including non-fusion and minimally invasive surgery. Even these technologies experienced moderate levels of growth in 2013 in Taiwan due to fierce price competition and maturing markets. Therefore, whereas the Chinese MIS spinal devices market is experiencing explosive growth and will do so through the forecast period, the Taiwanese MIS spinal devices market will maintain moderate levels of growth in the single-digits.

more...

Cosmetic Surgery, Facial Aesthetic and Medical Laser Market Report Suite | Asia-Pacific (China, India) | 2011-2017 | MedSuite

Medical aesthetic devices are generally used for conditions that are elective and, consequently, are not reimbursed by insurance policies. This has resulted in a market that is vulnerable to decline during economic recessionary periods. However, a number of domestic Chinese manufacturers offer products at prices significantly lower than those of international brands, which drove sales during the recent global financial crisis. The medical devices and pharmaceuticals discussed in this report span a wide range of indications and target consumers, and provide a number of treatments at various price points for consumers. In 2010, demand for affordable procedures exceeded that for more expensive treatments in both China and India. The same was true for treatments that were more minimally invasive as opposed to surgical alternatives. Medical aesthetic treatments are varied and advance at a faster pace than what is typically seen in other medical device markets.

more...

Female and Neonatal Diagnostic Devices Market Analysis, Size, Trends | Asia-Pacific | 2012-2018 | MedSuite

The Asia-Pacific women’s health market encompasses all aspects that pertain to women’s well-being, including bone and breast health, obstetrics and gynecology. This report includes markets for bone densitometry (central and peripheral), breast biopsy devices (spring loaded core needles, VABB devices and fine needle aspiration), breast imaging (digital and analog mammography and breast MRI coils), OB/GYN ultrasound imaging (transvaginal and transabdominal), assisted reproduction (embryo transfer catheters, oocyte retrieval needles, micropipettes and reproductive media), endometrial resection (monopolar electrodes and resectoscopes), hysteroscopes (rigid and flexible), colposcopes, female urinary incontinence slings and pelvic floor reconstruction. The report also includes an analysis of the developing markets of global endometrial ablation, uterine fibroid embolization and fluid management.

This report describes the conditions that women’s health professionals deal with in the Asia-Pacific region, including osteoporosis, cancer, incontinence, infertility and menstrual complications. A few sub-specialties are emerging, particularly in gynecology, as urologists and oncologists move into the territory originally considered a gynecology specialty, and gynecologists move into urology and other surgical specialties.

more...

Minimally Invasive Spinal Devices Market Report Suite | Australia, Japan, South Korea | 2011-2017 | MedSuite

The Asia-Pacific spinal implant markets comprises two segments: minimally invasive thoracolumbar fixation and minimally invasive interbody fusion. The countries examined in this report (Australia, Japan and South Korea) have young and rapidly growing minimally invasive spinal implant markets. Growth in the minimally invasive surgery (MIS) spinal implant market is largely driven by the advantages of MIS: reduced trauma, shorter hospital stays, lower post-operative medication use and earlier return to everyday routines. However, growth is expected to slow over the 2011–2017 forecast period due to the increasing penetration of MIS procedures and growth of the competing motion preservation market.

more...

Spinal Implants and VCF Market Report Suite | Asia-Pacific (Australia, Japan, Korea) | 2011-2017 | MedSuite

The combined Asia-Pacific spinal implant market comprises three main segments: spinal fusion implants, non-fusion implants and vertebral compression fracture (VCF) treatments. The countries examined in this report (Australia, Japan and South Korea) all have stable traditional spinal fusion markets. As a result, the majority of growth in the Asia-Pacific spinal implant markets is due to the proliferation of newer technologies, including artificial discs, percutaneous vertebral augmentation (PVA) and dynamic stabilization systems. While non-fusion markets are expected to grow rapidly, persistent changes to device approval and reimbursement have created volatility in these segments.

more...

Spinal Implants, MIS and VCF Market Report Suite | Asia-Pacific (China, Taiwan) | 2011-2017 | MedSuite

The combined Chinese and Taiwanese spinal implant market comprises three main segments: spinal fusion implants, non-fusion implants and vertebral compression fracture (VCF) treatments. Despite the geographical proximity of China and Taiwan, the spinal implant markets in these two countries differ substantially. The Taiwanese market is mature and stable. As a result, the majority of growth in the Taiwanese market is due to the proliferation of newer technologies, including artificial discs, percutaneous vertebral augmentation (PVA) and minimally invasive surgery (MIS) solutions. Conversely, in China, increasing access to healthcare in rural areas, growing healthcare investment and a rise in the number of trained orthopedic surgeons have led to rapid growth in nearly every spinal implant market segment.

more...

Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices Market Report Suite | Japan, South Korea, Australia | 2011-2017 | MedSuite

Medical aesthetic devices are generally used for conditions that are elective and, consequently, are not reimbursed by third-party providers. This has resulted in a market that is vulnerable to decline during recessionary economic conditions. However,
a number of key products have significant demand and brand name recognition, which has driven sales through this period. The medical devices and pharmaceuticals discussed in this report span a wide range of indications and target consumers; this provides a number of alternative treatments at various price points for consumers to choose from. During the recession of 2008 and 2009, the more affordable procedures generally fared better than more expensive treatments. The same was also true for treatments that were minimally invasive compared to surgical alternatives. Medical aesthetic treatments are varied and the products evolve at a faster pace than what is typically seen in other medical device markets.

more...

Orthopedic Biomaterials, Bone Grafting and Hyaluronic Acid Viscosupplementation Market Report Suite | Asia-Pacific | 2011-2017 | MedSuite

The Asia-Pacific markets include Australia, China, Japan and South Korea. The orthopedic biomaterials market comprises autologous bone grafts, bone graft substitutes (segmented into allografts, demineralized bone matrices and synthetics), hyaluronic acid (HA) viscosupplementation and bone morphogenetic protein (BMP) growth factor therapy. The market is approaching maturity, but is expected to continue to grow as a result of the aging Asia-Pacific population. BMP growth factor therapy was the fastest-growing segment in 2010, increasing almost 7% over the previous year.

more...

Wound and Tissue Managemenet Market Report Suite | Asia-Pacific | 2011-2017 | MedSuite

Wound and tissue management includes devices that treat wounds to the skin, dermal layer and adjacent subcutaneous tissues, as well as devices that manage trauma to tissue and blood vessels during surgery. Wound management devices treat external wounds, while dressings and negative pressure wound therapy (NPWT) aid the body’s innate ability to heal skin wounds, surgical wounds and chronic wounds. Devices used for tissue management help to stop bleeding, close surgical incisions and prevent scarring and adhesion of internal tissue. Wound closure devices hold tissue together long enough for the body to develop scar tissue.

The Asia Pacific countries that are covered in this report include: Japan, South Korea and Australia. This report on wound and tissue management includes the markets for wound closure devices, moist, antimicrobial and interactive wound dressings, hemostats, tissue sealants, anti-adhesion products and NPWT.

more...